Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-144969
Filing Date
2023-05-15
Accepted
2023-05-15 16:08:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d463876ddefa14a.htm DEFA14A 24425
  Complete submission text file 0001193125-23-144969.txt   25476
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38997 | Film No.: 23922190
SIC: 2834 Pharmaceutical Preparations